|Benefit-Cost Summary Statistics Per Participant|
|Taxpayers||($448)||Benefits minus costs||($3,886)|
|Participants||($1,349)||Benefit to cost ratio||($2.73)|
|Others||($596)||Chance the program will produce|
|Indirect||($451)||benefits greater than the costs||47 %|
|Net program cost||($1,041)|
|Benefits minus cost||($3,886)|
|Meta-Analysis of Program Effects|
|Outcomes measured||Treatment age||No. of effect sizes||Treatment N||Adjusted effect sizes(ES) and standard errors(SE) used in the benefit - cost analysis||Unadjusted effect size (random effects model)|
|First time ES is estimated||Second time ES is estimated|
Attention-deficit/hyperactivity disorder symptoms
Clinical diagnosis of attention-deficit/hyperactivity disorder (ADHD) or symptoms measured on a validated scale.
Major depressive disorder
Clinical diagnosis of major depression or symptoms measured on a validated scale.
Disruptive behavior disorder symptoms
Clinical diagnosis of a disruptive behavior disorder (e.g., conduct disorder, oppositional defiant disorder) or symptoms measured on a validated scale.
How well individuals (typically those who are developmentally disabled or seriously mentally ill) have adapted to activities of daily living.
Symptoms of internalizing behavior (e.g., sadness, anxiety, or withdrawal) measured on a validated scale.
Standardized, validated tests of academic achievement.
|Detailed Monetary Benefit Estimates Per Participant|
|Affected outcome:||Resulting benefits:1||Benefits accrue to:|
|Test scores||Labor market earnings associated with test scores||($587)||($1,378)||($727)||$0||($2,692)|
|Disruptive behavior disorder symptoms||Criminal justice system||$10||$0||$27||$5||$42|
|K-12 grade repetition||$2||$0||$0||$1||$4|
|K-12 special education||$25||$0||$0||$13||$38|
|Health care associated with disruptive behavior disorder||$101||$29||$104||$51||$285|
|Major depressive disorder||Labor market earnings associated with major depression||$0||$0||$0||$0||$0|
|Mortality associated with depression||$0||$0||$0||$0||$0|
|Program cost||Adjustment for deadweight cost of program||$0||$0||$0||($521)||($521)|
|Detailed Annual Cost Estimates Per Participant|
|Annual cost||Year dollars||Summary|
|Program costs||$2,008||2015||Present value of net program costs (in 2018 dollars)||($1,041)|
|Comparison costs||$956||2010||Cost range (+ or -)||20 %|
Benefits Minus Costs
Benefits by Perspective
Taxpayer Benefits by Source of Value
|Benefits Minus Costs Over Time (Cumulative Discounted Dollars)|
|The graph above illustrates the estimated cumulative net benefits per-participant for the first fifty years beyond the initial investment in the program. We present these cash flows in discounted dollars. If the dollars are negative (bars below $0 line), the cumulative benefits do not outweigh the cost of the program up to that point in time. The program breaks even when the dollars reach $0. At this point, the total benefits to participants, taxpayers, and others, are equal to the cost of the program. If the dollars are above $0, the benefits of the program exceed the initial investment.|
Abikoff, H., Ganeles, D., Reiter, G., Blum, C., Foley, C., & Klein, R.G. (1988). Cognitive training in academically deficient ADDH boys receiving stimulant medication. Journal of Abnormal Child Psychology, 16(4), 411-432.
Abikoff, H. & Gittelman, R. (1985). Hyperactive children treated with stimulants: Is cognitive training a useful adjunct? Archives of General Psychiatry, 42(10), 953-961.
Brown, R.T., Wynne, M.E., Borden, K.A., Clingerman, S.R., Geniesse, R., & Spunt, A.L. (1986). Methylphenidate and cognitive therapy in children with attention deficit disorder: A double-blind trial. Journal of Developmental and Behavioral Pediatrics, 7(3), 163-174.
Coelho, L.F., Barbosa, D.L.F., Rizzutti, S., Bueno, O.F.A., & Miranda, M.C. (2018). Group cognitive behavioral therapy for children and adolescents with ADHD. Psicologia: ReflexaÞo E Criìtica, 30(1), 11.
Fehlings, D.L., Roberts, W., Humphries, T., & Dawe, G. (1991). Attention deficit hyperactivity disorder: Does cognitive behavioral therapy improve home behavior? Journal of Developmental and Behavioral Pediatrics, 12(4), 223-228.
Sprich, S.E., Safren, S.A., Finkelstein, D., Remmert, J.E., & Hammerness, P. (2016). A randomized controlled trial of cognitive behavioral therapy for ADHD in medication-treated adolescents. Journal of Child Psychology and Psychiatry, and Allied Disciplines, 57(11), 1218-1226.
Vidal, R., Castells, J., Richarte, V., Palomar, G., Garcia, M., Nicolau, R., . . . Ramos-Quiroga, J.A. (2015). Group therapy for adolescents with attention-deficit/hyperactivity disorder: A randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry, 54(4), 275-282.